BioCentury
ARTICLE | Distillery Therapeutics

TMED9 inhibition for mucin 1 kidney disease

August 15, 2019 8:08 PM UTC

Blocking the vesicular cargo receptor TMED9 could treat mucin 1 kidney disease, a proteinopathy caused by a frameshift mutation in MUC1, and other misfolded protein diseases. The Harvard researchers i...